J&J has received a marketing authorization for its OTTAVA robot

Johnson & Johnson has officially obtained the green light to enter the U.S. robotic surgery market, currently dominated by Intuitive ​Surgical. The $600 billion market cap company has been granted a De Novo authorization for its OTTAVA™ Robotic Surgical System by the U.S. Food and Drug Administration (FDA), according to a Wednesday announcement. J&J said...